Baylor University Medical Center — Dallas, Texas

Public research footprint of Baylor University Medical Center, compiled from the ClinicalTrials.gov public registry.

511

Registered studies

110

Active

Recruiting now

303

Completed

Stopped or withdrawn

Most-studied conditions

Acute Lymphoblastic Leukemia · Multiple Myeloma · Recurrent Melanoma · Relapsed B-Cell Non-Hodgkin Lymphoma

Recently updated registry entries

NCT07623161 — A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are… (Recruiting)
NCT02143414 — Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in… (Active Not Recruiting)
NCT01274338 — Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Baylor University Medical Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.